Literature DB >> 18018812

Buprenorphine 101: treating opioid dependence with buprenorphine in an office-based setting.

Matthew Torrington1, Catherine P Domier, Maureen Hillhouse, Walter Ling.   

Abstract

This clinical observation provides a first look at differences between two patient subgroups, prescription opiate (PO) abusers and heroin abusers, presenting for office-based buprenorphine treatment. Medical and drug use histories, medication dose, treatment outcome, and demographic information were collected from the first 101 opiate-dependent adults entering treatment. The results indicate that PO abusers (n = 42) and heroin abusers (n = 59) differed in several demographic characteristics, drug use history, and treatment outcome. Physicians may benefit from this information by using it to tailor comprehensive treatment and medical care plans for opioid-dependent patients taking buprenorphine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18018812     DOI: 10.1300/J069v26n03_10

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  12 in total

1.  Spontaneous reductions in smoking during double-blind buprenorphine detoxification.

Authors:  Mollie E Patrick; Kelly E Dunn; Gary J Badger; Sarah H Heil; Stephen T Higgins; Stacey C Sigmon
Journal:  Addict Behav       Date:  2014-05-05       Impact factor: 3.913

2.  The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample.

Authors:  Suzanne Nielsen; Maureen Hillhouse; Roger D Weiss; Larissa Mooney; Jennifer Sharpe Potter; Joshua Lee; Marc N Gourevitch; Walter Ling
Journal:  Am J Addict       Date:  2013-09-24

3.  Health-related quality of life changes associated with buprenorphine treatment for opioid dependence.

Authors:  Dennis W Raisch; Heather M Campbell; David A Garnand; Mark A Jones; Mike R Sather; Rupali Naik; Walter Ling
Journal:  Qual Life Res       Date:  2011-10-11       Impact factor: 4.147

4.  Physicians' Decision-making When Implementing Buprenorphine With New Patients: Conjoint Analyses of Data From a Cohort of Current Prescribers.

Authors:  Hannah K Knudsen; Michelle R Lofwall; Sharon L Walsh; Jennifer R Havens; Jamie L Studts
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

5.  A randomized, double-blind evaluation of buprenorphine taper duration in primary prescription opioid abusers.

Authors:  Stacey C Sigmon; Kelly E Dunn; Kathryn Saulsgiver; Mollie E Patrick; Gary J Badger; Sarah H Heil; John R Brooklyn; Stephen T Higgins
Journal:  JAMA Psychiatry       Date:  2013-12       Impact factor: 21.596

6.  From research to the real world: buprenorphine in the decade of the Clinical Trials Network.

Authors:  Walter Ling; Petra Jacobs; Maureen Hillhouse; Albert Hasson; Christie Thomas; Thomas Freese; Steven Sparenborg; Dennis McCarty; Roger Weiss; Andrew Saxon; Allan Cohen; Michele Straus; Gregory Brigham; David Liu; Paul McLaughlin; Betty Tai
Journal:  J Subst Abuse Treat       Date:  2010-06

7.  Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth.

Authors:  Geetha A Subramaniam; Diane Warden; Abu Minhajuddin; Marc J Fishman; Maxine L Stitzer; Bryon Adinoff; Madhukar Trivedi; Roger Weiss; Jennifer Potter; Sabrina A Poole; George E Woody
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-11       Impact factor: 8.829

8.  Lifetime history of heroin use is associated with greater drug severity among prescription opioid abusers.

Authors:  Andrew C Meyer; Mollie E Miller; Stacey C Sigmon
Journal:  Addict Behav       Date:  2014-11-18       Impact factor: 3.913

9.  Buprenorphine tapering schedule and illicit opioid use.

Authors:  Walter Ling; Maureen Hillhouse; Catherine Domier; Geetha Doraimani; Jeremy Hunter; Christie Thomas; Jessica Jenkins; Albert Hasson; Jeffrey Annon; Andrew Saxon; Jeffrey Selzer; Joshua Boverman; Richard Bilangi
Journal:  Addiction       Date:  2009-02       Impact factor: 6.526

10.  Social workers' knowledge and perceptions of effectiveness and acceptability of medication assisted treatment of substance use disorders.

Authors:  Brian E Bride; Amanda J Abraham; Sara Kintzle; Paul M Roman
Journal:  Soc Work Health Care       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.